Sort
21,281 grants matching “influenza”
B cell immunity in HIV exposed uninfected infants in Kenya
$609,802Arlene Dent · Case Western Reserve University · R01 · FY2014 · AI
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$609,757Norbert Pardi · University Of Pennsylvania · R01 · FY2020 · AI
Financial Incentives and Variations in the Care of Medicare Beneficiaries
$609,740Bruce E. Landon · Harvard Medical School · R01 · FY2009 · AG
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
$609,523Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2024 · AI
Loss of cellular identity after influenza virus infection and effects on pulmonary function
$609,414Nicholas S Heaton · Duke University · R01 · FY2021 · HL
Clonal Dynamics of the antibody response
$609,409Gabriel D Victora · Rockefeller University · R01 · FY2025 · AI
Role of Diabetes in MERS Coronavirus Pathogenesis
$609,387Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2020 · AI
Clinical and Biostatistics Core
$609,199Wilbur H. Chen · Univ Of Maryland, College Park · U19 · FY2025 · AI
CAREER: Realizing the Potential of Behavioral Data Science for Population Health
$609,173Tim Althoff · University Of Washington · · FY2022 · CSE
Understanding the relationship between codon optimality and mRNA stability
$608,823Jeffery Coller · Johns Hopkins University · R35 · FY2022 · GM
Understanding the relationship between codon optimality and mRNA stability
$608,823Jeffery Coller · Johns Hopkins University · R35 · FY2023 · GM
Understanding the relationship between codon optimality and mRNA stability
$608,823Jeffery Coller · Johns Hopkins University · R35 · FY2024 · GM
Understanding the relationship between codon optimality and mRNA stability
$608,823Jeffery Coller · Johns Hopkins University · R35 · FY2025 · GM
Exploratory Center for Vaccinology Research (RMI)
$608,799Emory University · P20 · FY2005 · RR
PARP9-DTX3L Control Of Viral Infection and Airway Disease
$608,777Michael Jay Holtzman · Washington University · R01 · FY2020 · AI
PARP9-DTX3L Control Of Viral Infection and Airway Disease
$608,777Michael Jay Holtzman · Washington University · R01 · FY2019 · AI
PARP9-DTX3L Control Of Viral Infection and Airway Disease
$608,777Michael Jay Holtzman · Washington University · R01 · FY2017 · AI
PARP9-DTX3L Control Of Viral Infection and Airway Disease
$608,777Michael Jay Holtzman · Washington University · R01 · FY2021 · AI
Monocyte-derived alveolar macrophage drives inflammatory response to lung ozone exposure
$608,769Robert Matthew Tighe · Duke University · R01 · FY2023 · ES
A Novel Live Non-replicating Universal Vaccine for Influenza
$608,733Sally R. Sarawar · Biomedical Research Instit/ Southern, Ca · R01 · FY2018 · AI
Addressing Vaccine AcceptaNce in Carceral Settings through Community Engagement (ADVANCE)
$608,656Lisa Balzano Puglisi · Yale University · R01 · FY2023 · MD
Defining the Interplay Between Viral Adaptation and Host Proteostasis
$608,610Matthew Donald Shoulders · Massachusetts Institute Of Technology · R01 · FY2022 · AI
Respiratory Viruses and Airflow Obstruction after HCT
$608,596Michael J Boeckh · Fred Hutchinson Cancer Research Center · R01 · FY2006 · HL
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORK IN VIETNAM
$608,466Nguyen Tran Hien · National Institute Hygiene/Epidemiology · U50 · FY2009 · CI
Vaccine and Treatment Evaluation Units (VTEU)
$608,269Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2021 · AI